Gilvusmycin
Latest Information Update: 22 Jan 2007
Price :
$50 *
At a glance
- Originator Kirin Brewery
- Class Cytostatic antibiotics
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 20 Apr 1999 Preclinical development for Cancer in Japan (unspecified route)